Pdt Partners, LLC Procept Bio Robotics Corp Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$24.89 - $43.41 $481,297 - $839,419	-19,337 Reduced 46.54%	22,215 $931,000
Q3 2023 Nov 14, 2023	SELL	$30.02 - $38.81 $272,221 - $351,929	-9,068 Reduced 17.91%	41,552 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$26.7 - $37.02 $262,541 - $364,017	9,833 Added 24.11%	50,620 $1.79 Million
Q1 2023 May 15, 2023	BUY	$26.64 - $39.74 $924,141 - $1.38 Million	34,690 Added 568.97%	40,787 $1.16 Million
Q4 2022 Feb 14, 2023	SELL	$38.78 - $46.78 $5,118 - $6,174	-132 Reduced 2.12%	6,097 $253,000
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $192,476 - $315,498	6,229 New	6,229 $258,000

214

36.3M

251K

101K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $3.55B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.